Lindsey R. Baden

Lindsey R. Baden

Infectious Disease

450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 500 publications

Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.

Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.

Journal: The New England journal of medicine

Published: August 28, 2026

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

Journal: medRxiv : the preprint server for health sciences

Published: June 05, 2026

NEJM Outbreaks Update - Andes Hantavirus.

NEJM Outbreaks Update - Andes Hantavirus.

Journal: The New England journal of medicine

Published: May 27, 2026

Priming of Multiple HIV Neutralizing B Cell Precursors in Humans.

Priming of Multiple HIV Neutralizing B Cell Precursors in Humans.

Journal: medRxiv : the preprint server for health sciences

Published: May 18, 2026

Induction of multiple HIV-1 neutralizing B Cell Precursors in Humans.

Induction of multiple HIV-1 neutralizing B Cell Precursors in Humans.

Journal: medRxiv : the preprint server for health sciences

Published: May 18, 2026

Scientific synergy between prophylactic and therapeutic HIV vaccines-prevention and cure.

Scientific synergy between prophylactic and therapeutic HIV vaccines-prevention and cure.

Journal: NPJ vaccines

Published: April 24, 2026

Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).

Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).

Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Infectious diseases

Published: April 05, 2026

Reactogenicity and Immunogenicity of Adjuvanted and Nonadjuvanted RSV Vaccines in Solid Organ Transplant Recipients.

Reactogenicity and Immunogenicity of Adjuvanted and Nonadjuvanted RSV Vaccines in Solid Organ Transplant Recipients.

Journal: Transplantation direct

Published: March 16, 2026

Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of Long COVID: RECOVER-VITAL.

Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of Long COVID: RECOVER-VITAL.

Journal: Clinical trials (London, England)

Published: March 06, 2026

Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Journal: Communications medicine

Published: February 23, 2026

Showing 1-12 of 500

Last Updated: 09/26/2026